Subsequently, according to the different types of MSAs, RP-ILD patients were divided into the anti-ARS positive, anti-MDA-5 positive, and MSA-negative groups, with no difference of sCD206 levels among these subgroups of patients (p = 0.999) (Figure 2(b)). This evidence concerns the gene TPO and interstitial lung disease.